bpc-157 safety fda warning evidence human clinical trials BPC-157: What you need to know before you bpc-157 safety fda warning Exciting

It targets blood vessels that supply white adipose tissue, causing fat cells to shrink through apoptosis

One 10 mg retatrutide vial (lyophilized powder) One vial of bacteriostatic water (0.9% benzyl alcohol preservative) One 3 mL mixing syringe with a longer needle (21-23 gauge) Alcohol swabs (70% isopropyl) A clean, flat, well-lit work surface A vial label or marker for recording reconstitution date and concentration Optional: U-100 insulin syringes (0.5 mL or 1 mL) for drawing doses later Why bacteriostatic water specifically

AOD-9604s fat-mobilizing effects also create metabolic byproducts that the kidneys need to process

Advanced / Aggressive Approach (3 mL = ~6,667 mcg/mL) Advanced daily dose: 500 mcg total blend once daily ~8 units on a 20 mg vial, ~15 units on a 10 mg vial